These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 2822907)

  • 1. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists.
    Aanonsen LM; Wilcox GL
    J Pharmacol Exp Ther; 1987 Oct; 243(1):9-19. PubMed ID: 2822907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscimol, gamma-aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord.
    Aanonsen LM; Wilcox GL
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1034-8. PubMed ID: 2467978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of excitatory amino acids by divalent cations. A novel means for distinguishing N-methyl-D-aspartic acid-, kainate- and quisqualate-mediated actions in the mouse spinal cord.
    Hornfeldt CS; Larson AA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1064-8. PubMed ID: 2574739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice.
    Aanonsen LM; Wilcox GL
    Neurosci Lett; 1986 Jun; 67(2):191-7. PubMed ID: 2425302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA and non-NMDA receptors mediating nociceptive and non-nociceptive transmission in spinal cord of cat.
    Song XJ; Zhao ZQ
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):481-5. PubMed ID: 8010042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice.
    Gadotti VM; Tibola D; Paszcuk AF; Rodrigues AL; Calixto JB; Santos AR
    Brain Res; 2006 Jun; 1093(1):116-22. PubMed ID: 16765330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
    Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
    Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epinephrine and norepinephrine modulate neuronal responses to excitatory amino acids and agonists in frog spinal cord.
    Wohlberg CJ; Hackman JC; Davidoff RA
    Synapse; 1987; 1(2):202-7. PubMed ID: 2905530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.
    Björkman R
    Acta Anaesthesiol Scand Suppl; 1995; 103():1-44. PubMed ID: 7725891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.
    DeLander GE; Wahl JJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1090-5. PubMed ID: 2481030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level.
    Hylden JL; Wilcox GL
    J Pharmacol Exp Ther; 1983 Aug; 226(2):398-404. PubMed ID: 6192235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtypes of excitatory amino acid receptors involved in the stimulation of [3H]dopamine release from cell cultures of rat ventral mesencephalon.
    Mount H; Quirion R; Kohn-Alexander J; Boksa P
    Synapse; 1990; 5(4):271-80. PubMed ID: 2163120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM; White TD; Sawynok J
    J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal antinociceptive effects of excitatory amino acid antagonists: quisqualate modulates the action of N-methyl-D-aspartate.
    Raigorodsky G; Urca G
    Eur J Pharmacol; 1990 Jun; 182(1):37-47. PubMed ID: 1976097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excitotoxicity in the embryonic chick spinal cord.
    Stewart GR; Olney JW; Pathikonda M; Snider WD
    Ann Neurol; 1991 Dec; 30(6):758-66. PubMed ID: 1686386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
    Yoshida A; Mobarakeh JI; Sakurai E; Sakurada S; Orito T; Kuramasu A; Kato M; Yanai K
    Eur J Pharmacol; 2005 Oct; 522(1-3):55-62. PubMed ID: 16212954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral classification of excitatory amino acid receptors in mouse spinal cord.
    Urca G; Raigorodsky G
    Eur J Pharmacol; 1988 Aug; 153(2-3):211-20. PubMed ID: 2903061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
    DeLander GE; Wahl JJ
    Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.